Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 133,026 | 70,106 | 246,662 | 76,497 | 81,331 |
| Marketable Securities | 122,573 | 235,366 | 252,272 | 210,344 | 208,619 |
| Receivables | 47,139 | 28,208 | 25,506 | 24,624 | N/A |
| Inventories | 17,308 | 15,024 | 6,674 | 2,355 | N/A |
| TOTAL | $326,376 | $355,814 | $534,853 | $316,789 | $308,915 |
| Non-Current Assets | |||||
| PPE Net | 202 | 185 | 150 | 166 | 173 |
| Investments And Advances | 273,382 | 200,616 | 57,148 | 7,002 | 0 |
| Intangibles | 4,374 | 4,861 | 5,347 | 5,832 | 6,318 |
| Other Non-Current Assets | 4,054 | 2,354 | 2,397 | 2,517 | 2,686 |
| TOTAL | $282,012 | $208,016 | $65,042 | $15,517 | $9,177 |
| Total Assets | $608,388 | $563,830 | $599,895 | $332,306 | $318,092 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,386 | 12,435 | 8,145 | 6,216 | 5,483 |
| Accrued Expenses | 5,723 | 9,677 | 7,248 | 8,539 | 6,524 |
| Other current liabilities | 38,777 | 38,525 | 17,163 | 5,512 | 3,127 |
| TOTAL | $58,049 | $61,363 | $33,253 | $20,943 | $15,731 |
| Non-Current Liabilities | |||||
| Long Term Debt | 49,871 | 49,863 | 49,854 | 49,845 | 49,836 |
| Other Non-Current Liabilities | 4,668 | 2,489 | 21,983 | 21,378 | 20,264 |
| TOTAL | $54,539 | $52,352 | $71,837 | $71,223 | $70,100 |
| Total Liabilities | $112,588 | $113,715 | $105,090 | $92,166 | $85,831 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,120 | 51,624 | 53,710 | 53,145 | 50,394 |
| Common Shares | 52 | 52 | 54 | 50 | 49 |
| Retained earnings | -399,992 | -431,370 | -474,728 | -500,741 | -496,033 |
| Other shareholders' equity | -1,838 | 415 | 360 | 85 | 226 |
| TOTAL | $495,800 | $450,115 | $494,805 | $240,140 | $232,261 |
| Total Liabilities And Equity | $608,388 | $563,830 | $599,895 | $332,306 | $318,092 |